Bharati R Dhruva

Array ( [id] => 11922900 [patent_doc_number] => 09790471 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-10-17 [patent_title] => 'Ex vivo proliferation of epithelial cells' [patent_app_type] => utility [patent_app_number] => 15/296831 [patent_app_country] => US [patent_app_date] => 2016-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 44 [patent_no_of_words] => 47903 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 163 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15296831 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11421637 [patent_doc_number] => 20170029780 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-02-02 [patent_title] => 'EX VIVO PROLIFERATION OF EPITHELIAL CELLS' [patent_app_type] => utility [patent_app_number] => 15/296920 [patent_app_country] => US [patent_app_date] => 2016-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 47820 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15296920 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17621190 [patent_doc_number] => 11340238 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-05-24 [patent_title] => Method for detecting neutralizing antibodies against recombinant human insulin in human serum [patent_app_type] => utility [patent_app_number] => 15/767595 [patent_app_country] => US [patent_app_date] => 2016-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 6942 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 246 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15767595 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16244842 [patent_doc_number] => 10744170 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-08-18 [patent_title] => Combination treatment [patent_app_type] => utility [patent_app_number] => 15/768147 [patent_app_country] => US [patent_app_date] => 2016-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5750 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15768147 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11554233 [patent_doc_number] => 20170100479 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-04-13 [patent_title] => 'Activation Of Immune-Related Signaling Pathways In Cells Via Optofection' [patent_app_type] => utility [patent_app_number] => 15/288910 [patent_app_country] => US [patent_app_date] => 2016-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8695 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15288910 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11436412 [patent_doc_number] => 20170037434 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-02-09 [patent_title] => 'CHROMOSOMAL MODIFICATION INVOLVING THE INDUCTION OF DOUBLE-STRANDED DNA CLEAVAGE AND HOMOLOGOUS RECOMBINATION AT THE CLEAVAGE SITE' [patent_app_type] => utility [patent_app_number] => 15/281242 [patent_app_country] => US [patent_app_date] => 2016-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8998 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15281242 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14662711 [patent_doc_number] => 10369232 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-08-06 [patent_title] => Allele selective gene editing and uses thereof [patent_app_type] => utility [patent_app_number] => 15/272107 [patent_app_country] => US [patent_app_date] => 2016-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 17314 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15272107 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11364336 [patent_doc_number] => 20170002317 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-01-05 [patent_title] => 'CONVERSION OF NON-NEURONAL CELLS INTO NEURONS' [patent_app_type] => utility [patent_app_number] => 15/261353 [patent_app_country] => US [patent_app_date] => 2016-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 3456 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15261353 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11383195 [patent_doc_number] => 20170009252 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-01-12 [patent_title] => 'VECTORS AND METHODS FOR THE EFFICIENT GENERATION OF INTEGRATION/TRANSGENE-FREE INDUCED PLURIPOTENT STEM CELLS FROM PERIPHERAL BLOOD CELLS' [patent_app_type] => utility [patent_app_number] => 15/261803 [patent_app_country] => US [patent_app_date] => 2016-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 16924 [patent_no_of_claims] => 70 [patent_no_of_ind_claims] => 47 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15261803 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17434771 [patent_doc_number] => 11260077 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-03-01 [patent_title] => Process for obtaining a sprinkling compound of microvascular endothelial skin cells and mesenchymal stem cells and method of application for tissue regeneration [patent_app_type] => utility [patent_app_number] => 15/758101 [patent_app_country] => US [patent_app_date] => 2016-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10607 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 131 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15758101 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11663786 [patent_doc_number] => 20170152506 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-06-01 [patent_title] => 'INACTIVATION OF LYMPHOCYTE IMMUNOLOGICAL CHECKPOINTS BY GENE EDITING' [patent_app_type] => utility [patent_app_number] => 15/249593 [patent_app_country] => US [patent_app_date] => 2016-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6183 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15249593 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11742879 [patent_doc_number] => 20170196951 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-07-13 [patent_title] => 'POLYVALENT ANTI-TUMOR FIBROBLAST VACCINE' [patent_app_type] => utility [patent_app_number] => 15/231759 [patent_app_country] => US [patent_app_date] => 2016-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8053 [patent_no_of_claims] => 73 [patent_no_of_ind_claims] => 54 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15231759 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13774803 [patent_doc_number] => 20190000940 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-01-03 [patent_title] => COMPOSITIONS AND METHODS FOR THE TREATMENT OF AADC DEFICIENCY [patent_app_type] => utility [patent_app_number] => 15/749019 [patent_app_country] => US [patent_app_date] => 2016-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 58019 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -47 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15749019 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12445518 [patent_doc_number] => 09981019 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-05-29 [patent_title] => Methods and materials for reducing the severity of viral infections [patent_app_type] => utility [patent_app_number] => 15/222048 [patent_app_country] => US [patent_app_date] => 2016-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 12 [patent_no_of_words] => 12702 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15222048 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13970761 [patent_doc_number] => 10214723 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-02-26 [patent_title] => Gene editing in the oocyte by Cas9 nucleases [patent_app_type] => utility [patent_app_number] => 15/209516 [patent_app_country] => US [patent_app_date] => 2016-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14852 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 150 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15209516 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13182547 [patent_doc_number] => 10106777 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-10-23 [patent_title] => Directed differentiation and maturation of pluripotent cells into hepatocyte like cells by modulation of Wnt-signalling pathway [patent_app_type] => utility [patent_app_number] => 15/204466 [patent_app_country] => US [patent_app_date] => 2016-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 79 [patent_figures_cnt] => 34 [patent_no_of_words] => 11826 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15204466 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14058383 [patent_doc_number] => 10233475 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-03-19 [patent_title] => Antibody composition-producing cell [patent_app_type] => utility [patent_app_number] => 15/201679 [patent_app_country] => US [patent_app_date] => 2016-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 52 [patent_figures_cnt] => 74 [patent_no_of_words] => 72009 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 128 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15201679 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11269135 [patent_doc_number] => 20160331683 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-11-17 [patent_title] => 'WATER-IN-OIL TYPE EMULSION FOR TREATING A DISEASE OF THE EYE' [patent_app_type] => utility [patent_app_number] => 15/193508 [patent_app_country] => US [patent_app_date] => 2016-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3562 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15193508 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13675661 [patent_doc_number] => 20160376564 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-12-29 [patent_title] => Nucleic Acids and Polypeptides for Utilizing Plant Biomass [patent_app_type] => utility [patent_app_number] => 15/191482 [patent_app_country] => US [patent_app_date] => 2016-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22554 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15191482 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11090747 [patent_doc_number] => 20160287716 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-10-06 [patent_title] => 'METHOD FOR DELIVERY OF A BIOACTIVE SUBSTANCE NEAR/INTO A TARGET CELL' [patent_app_type] => utility [patent_app_number] => 15/185271 [patent_app_country] => US [patent_app_date] => 2016-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 4755 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15185271 [rel_patent_id] =>[rel_patent_doc_number] =>)